Literature DB >> 2870055

Secreted adenylate cyclase of Bordetella pertussis: calmodulin requirements and partial purification of two forms.

R H Kessin, J Franke.   

Abstract

The extracellular adenylate cyclase of Bordetella pertussis was partially purified and found to contain high- and low-molecular-weight species. The high-molecular-weight form had a variable molecular weight with a peak at about 700,000. The smaller species had a molecular weight of 60 to 70,000 as determined by gel filtration. The low-molecular-weight form could be derived from the high-molecular-weight species. The high-molecular-weight complex purified from the cellular supernatant was highly stimulated by calmodulin, while the low-molecular-weight enzyme was much less stimulated. Active enzyme could be recovered from sodium dodecyl sulfate (SDS) gels at positions corresponding to molecular weights of about 50,000 and 65,000. Active low-molecular-weight enzyme recovered from SDS gels migrated with a molecular weight of about 50,000, which coincides with a coomassie blue-stained band. However, when both high- and low-molecular weight preparations were analyzed in 8 M urea isoelectrofocusing gels, the enzyme activity recovered did not comigrate with stained protein bands. The enzyme recovered from denaturing isoelectrofocusing or SDS gels was activated by calmodulin, indicating a direct interaction of calmodulin and enzyme. The high-molecular-weight form of the enzyme showed increasing activity with calmodulin concentrations ranging from 0.1 to 500 nM, while the low-molecular-weight form was fully activated by calmodulin at 20 nM. Adenylate cyclase on the surface of living cells was activated by calmodulin in a manner which resembled that found for the high-molecular-weight form.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2870055      PMCID: PMC214590          DOI: 10.1128/jb.166.1.290-296.1986

Source DB:  PubMed          Journal:  J Bacteriol        ISSN: 0021-9193            Impact factor:   3.490


  19 in total

1.  Pertussis toxin and extracytoplasmic adenylate cyclase as virulence factors of Bordetella pertussis.

Authors:  A A Weiss; E L Hewlett; G A Myers; S Falkow
Journal:  J Infect Dis       Date:  1984-08       Impact factor: 5.226

2.  The cyclic nucleotide phosphodiesterase inhibitory protein of Dictyostelium discoideum. Purification and characterization.

Authors:  J Franke; R H Kessin
Journal:  J Biol Chem       Date:  1981-07-25       Impact factor: 5.157

3.  Assay of calmodulin with Bordetella pertussis adenylate cyclase.

Authors:  A Goldhammer; J Wolff
Journal:  Anal Biochem       Date:  1982-07-15       Impact factor: 3.365

4.  Amphiphile-mediated activation of soluble adenylate cyclase of Bordetella pertussis.

Authors:  J Wolff; G H Cook
Journal:  Arch Biochem Biophys       Date:  1982-05       Impact factor: 4.013

5.  Calcium-independent stimulation of Bordetella pertussis adenylate cyclase by calmodulin.

Authors:  D V Greenlee; T J Andreasen; D R Storm
Journal:  Biochemistry       Date:  1982-05-25       Impact factor: 3.162

6.  Calcium-independent activation of adenylate cyclase by calmodulin.

Authors:  M C Kilhoffer; G H Cook; J Wolff
Journal:  Eur J Biochem       Date:  1983-06-01

7.  A simplification of the protein assay method of Lowry et al. which is more generally applicable.

Authors:  G L Peterson
Journal:  Anal Biochem       Date:  1977-12       Impact factor: 3.365

8.  Anthrax toxin edema factor: a bacterial adenylate cyclase that increases cyclic AMP concentrations of eukaryotic cells.

Authors:  S H Leppla
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

9.  Phagocyte impotence caused by an invasive bacterial adenylate cyclase.

Authors:  D L Confer; J W Eaton
Journal:  Science       Date:  1982-09-03       Impact factor: 47.728

10.  Soluble adenylate cyclase from the culture medium of Bordetella pertussis: purification and characterization.

Authors:  E Hewlett; J Wolff
Journal:  J Bacteriol       Date:  1976-08       Impact factor: 3.490

View more
  9 in total

1.  Deletions affecting hemolytic and toxin activities of Bordetella pertussis adenylate cyclase.

Authors:  J Bellalou; H Sakamoto; D Ladant; C Geoffroy; A Ullmann
Journal:  Infect Immun       Date:  1990-10       Impact factor: 3.441

Review 2.  Pertussis: the disease and new diagnostic methods.

Authors:  R L Friedman
Journal:  Clin Microbiol Rev       Date:  1988-10       Impact factor: 26.132

Review 3.  Mechanisms of bacterial pathogenicity that involve production of calmodulin-sensitive adenylate cyclases.

Authors:  H R Masure; R L Shattuck; D R Storm
Journal:  Microbiol Rev       Date:  1987-03

4.  Bordetella pertussis adenylate cyclase: effects of affinity-purified adenylate cyclase on human polymorphonuclear leukocyte functions.

Authors:  R L Friedman; R L Fiederlein; L Glasser; J N Galgiani
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

5.  Adenylate cyclase toxin of Bordetella pertussis: production, purification, and partial characterization.

Authors:  M S Leusch; S Paulaitis; R L Friedman
Journal:  Infect Immun       Date:  1990-11       Impact factor: 3.441

6.  Dissociation of catalytic and invasive activities of Bordetella pertussis adenylate cyclase.

Authors:  A Raptis; L Knipling; J Wolff
Journal:  Infect Immun       Date:  1989-06       Impact factor: 3.441

7.  Effect of methyl-cyclodextrin on adenylate cyclase activity of Bordetella pertussis.

Authors:  D F Hozbor; A Samo; O M Yantorno
Journal:  World J Microbiol Biotechnol       Date:  1991-05       Impact factor: 3.312

8.  Bordetella pertussis adenylate cyclase: isolation and purification by calmodulin-sepharose 4B chromatography.

Authors:  R L Friedman
Journal:  Infect Immun       Date:  1987-01       Impact factor: 3.441

9.  Bordetella pertussis adenylate cyclase: purification and characterization of the toxic form of the enzyme.

Authors:  A Rogel; J E Schultz; R M Brownlie; J G Coote; R Parton; E Hanski
Journal:  EMBO J       Date:  1989-09       Impact factor: 11.598

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.